Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results
- PMID: 17947739
- DOI: 10.1200/JCO.2007.13.3918
Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results
Comment on
-
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.J Clin Oncol. 2007 Jan 1;25(1):32-42. doi: 10.1200/JCO.2006.06.7405. J Clin Oncol. 2007. PMID: 17194903
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
